围手术期
医学
心动过缓
心肌梗塞
重症监护医学
心力衰竭
不利影响
冲程(发动机)
麻醉
内科学
心率
血压
机械工程
工程类
作者
Xiaoxiao Wang,Claudia Fernandez Robles,Miklós D. Kertai
出处
期刊:Current Opinion in Anesthesiology
[Ovid Technologies (Wolters Kluwer)]
日期:2020-04-23
卷期号:33 (3): 417-422
被引量:7
标识
DOI:10.1097/aco.0000000000000853
摘要
Purpose of review Although the indications for β-blockers in the management of patients with congestive heart failure and myocardial infarction are well established, the use of β-blockers in the perioperative setting remains controversial. Recent findings Since 2008 PeriOperative ISchemic Evaluation Trial, there have been numerous studies suggesting that perioperative β-blockers are associated with adverse events such as hypotension, bradycardia, increased mortality, and stroke. Summary In this article, we review the most recent evidence to suggest an approach to perioperative β-blocker use tailored to patient and surgical risk factors. We also review recent studies on off-label uses for perioperative β-blockers.
科研通智能强力驱动
Strongly Powered by AbleSci AI